Form 4: Clover Health Director Acquires Shares Through Restricted Stock Unit Vesting

Sentiment:

SEC Form 4 Filing


William G. Robinson Jr., a director at Clover Health Investments, acquired 60,975 shares of Class A Common Stock through the vesting of restricted stock units.

Summary

  • William G. Robinson Jr., a director of Clover Health Investments, acquired 60,975 shares of Class A Common Stock on January 6, 2025.
  • These shares were obtained through the vesting of time-based restricted stock units (RSUs).
  • The RSUs vested in full on the first anniversary of the grant date, January 6, 2025, contingent on Robinson's continued service as a director.
  • Following this transaction, Robinson directly owns 518,622 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed positively as it aligns interests. There are no negative implications.

Positives

  • The vesting of RSUs indicates a long-term commitment from the director to the company.
  • The increase in share ownership aligns the director's interests with those of other shareholders.

Industry Context

This is a standard transaction for a director receiving equity compensation, and is common in the healthcare industry.

Comparison to Industry Standards

  • Equity compensation through RSUs is a common practice for directors in publicly traded companies, including those in the healthcare sector.
  • Similar vesting schedules, often tied to continued service, are typical in director compensation packages.
  • Companies like UnitedHealth Group (UNH) and Humana (HUM) also use equity-based compensation for their directors, though the specific terms and amounts vary.

Stakeholder Impact

  • The transaction increases the director's stake in the company, aligning his interests with shareholders.
  • The vesting of RSUs is a standard practice and should not have a significant impact on other stakeholders.

Key Dates

DateDescription
01/06/2025Date of the transaction and vesting of the restricted stock units.
01/08/2025Date the Form 4 was signed.

Keywords

Clover Health, Director, Share Acquisition, Restricted Stock Units, RSU, Vesting, Class A Common Stock, Insider Trading, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.